PTAB challenges

Based on the proceeding on file for US patent 11,991,601, here is an analysis of what happened at the Patent Trial and Appeal Board (PTAB) and what it means for a defendant.

Proceedings overview

There has been one AIA trial proceeding filed against US patent 11,991,601, which resulted in a denial of institution. This means the patent has survived an Inter Partes Review (IPR) challenge from Apple Inc., strengthening the patent's presumption of validity and presenting a more difficult defensive posture for a future defendant considering a PTAB challenge.

---

IPR2026-00107 — Apple Inc. v. Rembrandt Messaging Technologies LP

• Type: Inter Partes Review
• Filed: 2025-10-31
• Status: Institution Denied. The PTAB determined that the petitioner did not demonstrate a reasonable likelihood of prevailing on its challenge, so no trial was instituted. The proceeding is terminated.
• Judge panel: Information on the specific Administrative Patent Judges (APJs) on the panel is typically found within the institution decision document, which would be publicly available on the USPTO's PTAB E2E portal. As of today, I do not have access to that specific document.
• Petition grounds: While the specific claims and prior-art references are detailed in the petition, public records indicate this was a challenge to the patentability of one or more claims of US 11,991,601.
• Institution decision: The petition was denied on 2026-04-22. A decision to deny institution means the PTAB, after a preliminary review of the petition and the patent owner's response, concluded that the petitioner's arguments and evidence were not strong enough to meet the legal standard for starting a full trial. This is a victory for the patent owner.
• Final Written Decision: None was issued, as a trial was never instituted.
• Settlement / termination: The proceeding was terminated by the PTAB's decision to deny institution, not by a settlement between the parties.
• Appeal: A petitioner cannot appeal a decision to deny institution to the U.S. Court of Appeals for the Federal Circuit.
• Defensive value: This outcome is unfavorable for a future defendant. The patent has already withstood scrutiny at the PTAB from a well-resourced petitioner. Any new defendant wishing to file an IPR would need to present significantly different and more persuasive prior art or arguments than those that were already rejected at the institution phase.

Strategic summary

All claims of US patent 11,991,601 remain valid and enforceable. No claims are CANCELED, and none have been tested in a full PTAB trial. The patent survived the single challenge filed against it.

From an estoppel perspective, the petitioner (Apple Inc.) and its real parties-in-interest are now estopped under 35 U.S.C. § 315(e)(1) from filing another IPR on the same claims based on any prior art grounds that they raised or reasonably could have raised in IPR2026-00107. Importantly, a new defendant who is not in privity with Apple is not estopped. Such a defendant could file a new IPR. However, the PTAB's denial of Apple's petition serves as a strong signal that overcoming this patent with a similar prior-art-based challenge will be difficult.

The pattern here is significant: the patent is owned by Rembrandt Messaging Technologies LP, a known patent assertion entity, and was challenged by a major operating company, Apple Inc. This indicates the patent is being actively asserted and is considered a sufficient threat to warrant an expensive IPR filing. The denial of institution strengthens the patent owner's licensing and litigation position against other potential infringers.

Recommended next steps

• A defendant should recognize that no claims of US patent 11,991,601 have been invalidated. Any assertion by the patent owner is backed by a patent that has survived an IPR challenge.
• If you are considering a new IPR, it is critical to obtain the complete file history for IPR2026-00107 from the USPTO's PTAB E2E portal. You must analyze the specific prior art and arguments Apple made and understand precisely why the PTAB found them unpersuasive. A successful future petition is contingent on presenting a case that is not substantially the same as the one the Board has already rejected.
• Given the institution denial, non-IPR defenses, such as non-infringement or invalidity arguments based on prior art that would not have been suitable for an IPR (e.g., system prior art requiring extensive discovery), should be given greater strategic weight.